These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1490777)

  • 1. Clinical pharmacology and pharmacoepidemiology: future challenges for the European Community.
    Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):449-52. PubMed ID: 1490777
    [No Abstract]   [Full Text] [Related]  

  • 2. European pharmacovigilance: an overview of pharmacovigilance inspections.
    Koster MC; van den Oetelaar AH
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):711-3. PubMed ID: 16142691
    [No Abstract]   [Full Text] [Related]  

  • 3. European pharmacovigilance legislation: has it led to implementation of pharmacovigilance inspections?
    Bleumink GS; in't Veld BA; Stricker BH
    Pharmacoepidemiol Drug Saf; 2001; 10(4):339-40. PubMed ID: 11760496
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M; Gill S; Fitzgerald M; Samii A
    J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology and pharmacoepidemiology: synergistic interactions.
    Jones JK
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):421-4. PubMed ID: 1490766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacoepidemiology].
    Hallas J; Sørensen HT
    Ugeskr Laeger; 2005 May; 167(20):2186-90. PubMed ID: 15987081
    [No Abstract]   [Full Text] [Related]  

  • 7. New regulatory rules for clinical trials in the United States and the European Union: key points and comparisons.
    Miossec M; Miossec P
    Arthritis Rheum; 2006 Dec; 54(12):3735-40. PubMed ID: 17133535
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving family ties: an examination of the complementary disciplines of pharmacoepidemiology and clinical pharmacology.
    Lehmann DF
    Pharmacoepidemiol Drug Saf; 2001; 10(1):63-8. PubMed ID: 11417071
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology information in summaries of product characteristics and package inserts.
    Arguello B; Fernandez-Llimos F
    Clin Pharmacol Ther; 2007 Nov; 82(5):566-71. PubMed ID: 17410119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of in-hospital medication use: an opportunity for clinical pharmacology.
    Atkinson AJ; Nordstrom K
    Clin Pharmacol Ther; 1996 Oct; 60(4):363-7. PubMed ID: 8873683
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacology and internal medicine].
    Kirch W; Mueller EA
    Med Klin (Munich); 2010 Mar; 105(3):191-2. PubMed ID: 20349296
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug surveillance within the pharmaceutical industry: present and future].
    Soto J; Sacristán JA; Alsar MJ; Galende I
    Med Clin (Barc); 1996 May; 106(17):665-9. PubMed ID: 8691914
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacology at the start of a new millennium. Larger assortment and individual drug dosing are coming].
    Fredholm BB; Sjöqvist F
    Lakartidningen; 2001 Feb; 98(6):534-9. PubMed ID: 11475239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does collaboration inside the European Union improve Finnish drug safety?].
    Palva E
    Duodecim; 2000; 116(24):2810-1. PubMed ID: 12077885
    [No Abstract]   [Full Text] [Related]  

  • 15. European commission consultation on pharmacovigilance.
    Waller P; Beard K; Egberts T; Evans S; Hallas J; Hasford J; Laporte JR; Moore N; Shakir S; Sturkenboom M
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):108-9. PubMed ID: 18058839
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of pharmacoepidemiology in drug development.
    Urquhart J
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):456-8. PubMed ID: 1490779
    [No Abstract]   [Full Text] [Related]  

  • 17. Points to consider: the roles of surveillance and epidemiology in advancing drug safety.
    Edwards R; Faich G; Tilson H;
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):665-7. PubMed ID: 15719353
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new system for drug control in the EEC. Role of Sweden in an active monitoring of adverse effects].
    Wiholm BE; Beermann B; Strandberg K
    Lakartidningen; 1995 Jan; 92(3):129-32. PubMed ID: 7837842
    [No Abstract]   [Full Text] [Related]  

  • 19. [Opinion survey of European pharmacovigilance: opinion of French practitioners].
    Pierfitte C; Hanesse B; Royer RJ
    Therapie; 1995; 50(2):171-2. PubMed ID: 7631296
    [No Abstract]   [Full Text] [Related]  

  • 20. [Brief introduction to pharmacoepidemiology].
    Geng G; Edlavitch SA
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Dec; 11(6):368-71. PubMed ID: 2276190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.